Showing results (211-220 of 281) with videos related to

Sort By:
Pageof 29
Lupus|October 10, 2019
Implementation and dissemination of an African American popular opinion model to improve lupus awareness: an academic-community partnershipC R Phillip, K Mancera-Cuevas, C Leatherwood, et al.
Lupus|January 11, 2007
Mortality related to cerebrovascular disease in systemic lupus erythematosusS Bernatsky, A Clarke, D D Gladman, et al.
Lupus|August 31, 2007
Clinical manifestations and coronary artery disease risk factors at diagnosis of systemic lupus erythematosus: data from an international inception cohortM B Urowitz, D Gladman, D Ibañez, et al.
Arthritis and Rheumatism|February 2, 2008
Accumulation of coronary artery disease risk factors over three years: data from an international inception cohortM B Urowitz, D Gladman, D Ibañez, et al.
The Journal of Rheumatology|June 1, 1987
Low serum antimycobacterial glycolipid antibody titers in the sera of patients with systemic lupus erythematosus associated with central nervous system involvementH Teplizki, D Buskila, S Argov, et al.
Infection and Immunity|August 1, 1976
Rat polyvinyl sponge model for the study of infections: initial investigationsH D Isenberg, S L Wiener, G A Isenberg, et al.
Infection and Immunity|August 1, 1976
Rat polyvinyl sponge model for the study of infections: host factors and microbial proliferationH D Isenberg, S L Wiener, G A Isenberg, et al.
Clinical Rheumatology|November 1, 1996
Standardising joint assessment in rheumatoid arthritisD L Scott, E H Choy, A Greeves, et al.
British Journal of Rheumatology|June 1, 1996
Genetic analysis of TAP2 in systemic lupus erythematosus patients from two ethnic groupsL Ocal, K Russell, H Beynon, et al.
Lupus|November 29, 2007
Mycophenolate mofetil as induction and maintenance therapy for lupus nephritis: rationale and protocol for the randomized, controlled Aspreva Lupus Management Study (ALMS)A Sinclair, G Appel, M A Dooley, et al.
Pageof 29